Canada markets close in 8 minutes

Iovance Biotherapeutics, Inc. (2LB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
7.52-0.09 (-1.16%)
As of 08:32AM CEST. Market open.

Insider Roster

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date

BELLEMIN JEAN-MARC
Chief Financial Officer

Conversion of Exercise of derivative security

Jan 03, 2023

17,801

BILINSKY IGOR P
Chief Operating Officer

Conversion of Exercise of derivative security

Jun 03, 2024

39,758

DUKES IAIN D
Director

Purchase

Feb 20, 2024

54,000

GRAF FINCKENSTEIN FRIEDRICH
Officer

Conversion of Exercise of derivative security

Jun 03, 2024

44,486

MAYNARD RYAN D
Director

Purchase

May 31, 2022

7,500

MCPEAK MERRILL A
Director

Purchase

Feb 20, 2024

568,783

VOGT FREDERICK G
Chief Executive Officer

Conversion of Exercise of derivative security

Jun 03, 2024

147,325

WEISER MICHAEL
Director

Purchase

May 31, 2022

141,116

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.